Cargando…

Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases

Mesenchymal stem cells (MSC) secrete neuroprotective molecules that may be useful as an alternative to cell transplantation itself. Our purpose was to develop different pharmaceutical compositions based on conditioned medium (CM) of adipose MSC (aMSC) stimulated by and/or combined with nicotinamide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso-Alonso, Maria L., Srivastava, Girish K., Usategui-Martín, Ricardo, García-Gutierrez, Maria T., Pastor, José Carlos, Fernandez-Bueno, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336242/ https://www.ncbi.nlm.nih.gov/pubmed/32676122 http://dx.doi.org/10.1155/2020/9463548

Ejemplares similares

Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death
por: Usategui-Martín, Ricardo, et al.
Publicado: (2022)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
por: Labrador-Velandia, Sonia, et al.
Publicado: (2016)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
por: Belei, Oana, et al.
Publicado: (2023)

Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
por: Chaudhury, Dipesh, et al.
Publicado: (2008)

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019)

Vasoactive intestinal peptide regulates ileal goblet cell production in mice
por: Schwerdtfeger, Luke A., et al.
Publicado: (2020)

Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
por: Ataallah, Basma, et al.
Publicado: (2020)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
por: Privalov, Evgeny, et al.
Publicado: (2023)

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility
por: Nassif, A., et al.
Publicado: (1995)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
por: Wu, Dongmei, et al.
Publicado: (2011)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE)
por: Verma, Alok K., et al.
Publicado: (2017)

Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception
por: Zhu, Zhen-chuang, et al.
Publicado: (2019)

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system
por: Iwasaki, Mari, et al.
Publicado: (2019)

Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report
por: Thivacaren, Sritharan, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature
por: Yee, Shelby K., et al.
Publicado: (2022)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
por: Asano, Satoshi, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge
por: Lopes, Sara, et al.
Publicado: (2022)

Human retinal secretome: A cross-link between mesenchymal and retinal cells
por: Donato, Luigi, et al.
Publicado: (2023)

Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment
por: Chen, Xiaohong, et al.
Publicado: (2020)

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
por: Juarranz, Yasmina, et al.
Publicado: (2005)

The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
por: Villanueva-Romero, Raúl, et al.
Publicado: (2018)

Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts
por: Sato, Ayako, et al.
Publicado: (2019)

The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p
por: Cocco, Elisa, et al.
Publicado: (2010)

Rat Cerebellar Grafts Have (125)I-Vasoactive Intestinal Peptide Binding Sites
por: Moody, T. W., et al.
Publicado: (1992)

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.
por: Raderer, M., et al.
Publicado: (1998)

In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells
Publicado: (1984)

Vasoactive intestinal peptide inhibits the production of Salmonella-induced inflammatory cytokines by human monocytes
por: Askar, B, et al.
Publicado: (2014)

Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats
por: Xu, Chun-Lan, et al.
Publicado: (2018)

Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome
por: Goff, Kevin M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jkrq6ucg3ihb5ivmffc6jfb7au